← Back to headlines
FDA plans to relax testing rules to encourage biosimilar drugs: report
The U.S. Food and Drug Administration (FDA) is reportedly planning to ease testing requirements for biosimilar drugs, a move aimed at making it easier and faster to bring these less expensive alternatives to market.
Sources
Showing 0 of 2 sources
No articles available in your preferred languages.
2 articles available in other languages below.
bloombergglg137d ago
FDA Plans to Loosen Testing Rules to Boost Biosimilar Drugs - Bloomberg.com
FDA Plans to Loosen Testing Rules to Boost Biosimilar Drugs Bloomberg.com
Read full article →seeking-alphaglg137d ago
FDA plans to relax testing rules to encourage biosimilar drugs: report
Read full article →Coverage Timeline
First report: seeking-alpha · 9 Mar, 10:44|Full coverage: 2 · 4h|Window: 4h
Left-leaningCenterRight-leaning
